This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BioProcess International US West
March 9-11, 2026
San Diego Convention CenterSan Diego, CA, USA
Book Now
Menu
Book Now
Key Sessions
Thomas Jostock, Ph.D.
Advanced Cell Line Development Technologies for High-Speed and Flexible Host Gene Modulation
Novartis
Aleah Li
Process Intensification Using HIPDOG for BCAT1-Knockout CHO Cell Culture
Pfizer
Paul Hanson, Ph.D.
Keynote Address - Navigating Emerging Supply Chain Risks in the PFAS Regulatory Landscape with an AI x Risk Management Tool
Takeda Pharmaceuticals
Philip Probert, Ph.D.
From Antibodies to RNA: Intensification Case Studies for the Future of Bioprocessing
CPI
Justin Skoble, Ph.D.
Scaling genome-edited allogeneic CAR-T manufacturing to increase access to cell therapies
Caribou Biosciences, Inc.
keyboard_arrow_right

Wednesday March 11 - PT (Pacific Time, GMT-08:00)

keyboard_arrow_leftSearch & Filter
search
Wednesday March 11 - PT (Pacific Time, GMT-08:00)
search
Showing 1 of 1 Streams
8:55am - 9:00am
Chairperson's Opening Remarks: Manufacturing Strategy & Bioprocessing 4.0
  • David Scherr, Ph.D. - Senior Scientist, AstraZeneca
9:00am - 9:30am
Upstream and Downstream Intensification Levers for Large Molecule Manufacturing
  • Nuno Pinto, Ph.D. - Director,, Merck & Co., Inc.
9:30am - 10:00am
Panel Discussion: Fueling Innovation: Modern Fundraising Strategies for Biotech
  • Courtney Young - CEO and Founder, MyoGene Bio
  • Cassidy Cantin - Associate Partner, Latham BioPharm Group, Sia/LBGLatham
  • Tari Suprapto, Ph.D. - Senior Director, Head of Search, Novo Nordisk
  • Pascal Krotee, Ph.D. - Principal, RiverVest Venture Partners
10:00am - 10:30am
Innovation Through Engineering: Creating a Novel CHO Host Cell Line to Strengthen CLD
  • Yash Patel, Ph.D. - Product Manager - CHO CLD Service, Sartorius
Showing 1 of 1 Streams
11:15am - 11:45am
Maximizing CMC Efficiency through In-house AD/PD Optimization for External Tech Transfers
  • Discuss the challenges of external tech transfers when outsourcing CDMOs for clinical manufacturing.
  • How to condense timelines and reduce costs through in-house utilization of AD/PD teams to perform parallel development with external partners.
  • Strategies to identify and mitigate risks for allogeneic therapies.
  • Isaura (Alex) Villalba - Associate Scientist, Tr1X, Inc.
11:45am - 12:15pm
Strategic Enable of Scale-Up Capability through Integrated Dynamic Bioprocessing
  • Yajing Zhao - Associate Scientist, Alexion AstraZeneca Rare Disease
12:15pm - 12:45pm
De-Risking CMC Pathways for Accelerated Clinical and Commercial Programs
  • Rohan Kulkarni, Ph.D. - Scientist II, Group Lead, Upstream Process Development, Bionova Scientific
Showing 1 of 1 Streams
1:55pm - 2:00pm
Chairperson's Remarks
  • Vilas Shukla, Ph.D. - Director, Large Molecule Global Engineering Projects, Johnson & Johnson Innovative Medicine
2:00pm - 2:30pm
Keynote Address - Navigating Emerging Supply Chain Risks in the PFAS Regulatory Landscape with an AI x Risk Management Tool
  • Paul Hanson, Ph.D. - Head (VP) of Lifecycle Management, Innovation, and Strategy, Takeda Pharmaceuticals
2:30pm - 3:00pm
How a Joint Audit Model Helps in Cell & Gene Therapy
  • Ben Mills - Senior Director, Operations (Joint Audit Program/Quality), Rx-360
Showing 1 of 1 Streams
3:45pm - 4:15pm
Standardizing Raw Material Characterization for Regulatory Acceptance

NIST reference materials for the biomanufacturing and biopharmaceutical industries.

In the last several years NIST has developed a number of reference materials (RMs) geared toward the biopharmaceutical industry. These include the NISTmAb, an NS0-produced IgG1k, the NISTCHO, a CHO cell line expressing the amino acid sequences of the NISTmAb, and the cNISTmAb, the product of the NISTCHO. All three RM materials are open access with minimal IP constraints to encourage open innovation and pre-competitive research. The properties of the RMs will be presented along with examples of how the community uses these materials.

  • Zvi Kelman, Ph.D. - Director, Biomolecular Labeling Laboratory, NIST
4:15pm - 4:45pm
Reimagining Operational Excellence in Biomanufacturing
  • Christian Berg - Senior Life Sciences Solutions Consultant, Emerson (on behalf of BioPhorum)
4:45pm - 5:15pm
Panel Discussion – The Next Decade in Biomanufacturing Strategy

A visionary panel on trends shaping the future: decentralized production, autonomous operations, evolving supply chains, and end-to-end continuous processes. Panelists will explore how digital and AI-enabled systems will define the next decade.

  • Vilas Shukla, Ph.D. - Director, Large Molecule Global Engineering Projects, Johnson & Johnson Innovative Medicine
  • Dan Oliver - CEO and Founder, Rejuvenate Bio
  • Andrew Harmon, MBA - Manager, Life Sciences Strategy Consulting, Sia Partners
  • Anthony Chikere, Ph.D. - Director, Process Development, Sangamo
Tuesday March 10
Filter
Streams
Clear
Formats
Choose Day